The latest “kick-and-kill” research to eliminate the HIV virus uncovered a potential obstacle in finding a cure.
Ketcia, a community health worker, sits with children during a PEPFAR-sponsored home healthcare visit in Robin,
A variety of antiretroviral drugs used to treat HIV infection. Courtesy of NIAID
A pill box containing once-daily antiretroviral treatments for HIV infection. Courtesy of NIAID
Conducting HIV testing among the social and risk networks of those recently diagnosed with HIV helps identify undiagnosed cases of HIV at significantly higher rates and at a lower cost than other testing approaches, finds a new study cond
David Margolis, MD. Courtesy of David Kinton, UNC School of Medicine
Transitioning away from a popular contraceptive shot known as DMPA could help protect women in Sub-Saharan Africa and other high-risk regions from becoming infected with HIV, according to a research review published in the Endocrine Socie
In the fight against the HIV epidemic, medication non-adherence remains a major challenge.
Research on HIV over the past decade has led to many promising ideas for vaccines to prevent infection by the AIDS virus, but very few candidate vaccines have been tested in clinical trials. One reason for this is the technical difficulty of manufacturing vaccines based on the envelope proteins of the virus, according to Phil Berman, who led development of a major component of the only vaccine to have shown any efficacy against HIV in a clinical trial.